Skip to main content

Gilead Sciences, Inc.

SEC CIK
0000882095
Latest filing
Aug 3, 2026

Holdings in Q3 2025

Holdings as of Sep 30, 2025, filed Nov 13, 2025. Long positions only; changes compare share counts with Q2 2025.

Institution overview
Positions
9
−5 vs. Q2 2025
Portfolio value
$1.79B
+$511.3M (+39.9%) vs. Q2 2025
Filed
Nov 13, 2025
SEC
Holdings of Gilead Sciences, Inc. in Q3 2025
SecurityClassSharesValue% of portfolioShare changeActionHistory
LKFTLakefront Biotherapeutics NVSPON ADR16,707,477$578.7M32.3%00.0%UnchangedHistory
ACLXArcellx, Inc.COMMON STOCK6,720,803$551.8M30.8%00.0%UnchangedHistory
RCUSArcus Biosciences, Inc.COM31,424,760$427.4M23.9%00.0%UnchangedHistory
ASMBAssembly Biosciences, Inc.COM NEW4,505,391$115.3M6.4%+2,295,920+103.9%AddedHistory
MRUSMerus N.V.COM452,527$42.6M2.4%00.0%UnchangedHistory
TNGXTango Therapeutics, Inc.COM4,854,443$40.8M2.3%00.0%UnchangedHistory
KYTXKyverna Therapeutics, Inc.COM4,126,119$24.8M1.4%00.0%UnchangedHistory
XLOXilio Therapeutics, Inc.COM9,105,451$7.67M0.4%00.0%UnchangedHistory
CYPHCypherpunk Technologies Inc.COM NEW5,319,148$2.41M0.1%00.0%UnchangedHistory

Sold out since Q2 2025 (5)

Positions held at the end of Q2 2025 that are gone from this filing.

Positions of Gilead Sciences, Inc. sold out since Q2 2025
SecurityClassShares in Q2 2025Value in Q2 2025% of portfolio in Q2 2025History
HOOKHOOKIPA Pharma Inc.COM1,875,945$2.35M0.2%History
ALLOAllogene Therapeutics, Inc.COM1,156,689$1.31M0.1%History
KLRSKalaris Therapeutics, Inc.COM317,789$848.5K0.1%History
IMAImageneBio, Inc.COM348,534$467.1K<0.1%History
BRNSBarinthus Biotherapeutics plc.ADS99,478$92.5K<0.1%History